In the pocket: New paclitaxel analog kills more cancer cells than natural product

Simple item page
dc.contributor.authorTrulove, Susanen
dc.coverage.spatialBlacksburg, Va.en
dc.date.accessioned2013-05-06T19:31:15Zen
dc.date.available2013-05-06T19:31:15Zen
dc.date.issued2004-03-29en
dc.description.abstractA multi-university research team led by Virginia Tech University Distinguished Professor of Chemistry David G.I. Kingston has succeeded in enhancing the structure of paclitaxel (Taxol(TM)) to make it more effective in killing cancer cells.en
dc.format.mimetypetext/htmlen
dc.identifier.urihttp://hdl.handle.net/10919/20831en
dc.publisherVirginia Tech. University Relationsen
dc.rightsIn Copyrighten
dc.rights.holderVirginia Tech. University Relationsen
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.titleIn the pocket: New paclitaxel analog kills more cancer cells than natural producten
dc.typePress releaseen
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 1 of 1
Name:
2004-132.html
Size:
6.39 KB
Format:
Hypertext Markup Language
Download

Collections

Virginia Tech News